Alzheimer's disease (AD) is a neurodegenerative brain disorder that causes diminished memory and cognitive decline, and it affects millions of people throughout the world. In particular, acetylcholinesterase (AChE) inhibitors have been studied as a means of studying the cholinergic system, since low acetylcholine levels, T protein aggregation, oxidative stress, inflammatory processes, and abnormal beta-amyloid, are all related to AD